Friday, Dr. Reddy's Laboratories Ltd. (RDY) announced its second-quarter results under International Financial Reporting Standards or IFRS.
Second-quarter profit for the period attributable to equity holders of the company increased to $45 million from $22 million in the prior year period. Earnings per share for the quarter was $0.3 per share, up from $0.1 per share last year.
Revenue for the quarter rose to $382 million from $336 million in the comparable period.
For comments and feedback: editorial@rttnews.com